Our findings in the heterotopic NSCLC mouse tumor models add to the results of, previous studies, which showed decreased tumorigenesis in mice genetically deficient in cPLA2 or those treated with chemical inhibitors of the enzyme [16], [26]. The gene discussed is PLA2G4A; the disease is neoplasm.